1. Kersey JH, Spector BD, and Good RA: Primary immunodeficiency diseases and cancer: The immunodeficiencycancer registry, Int J Cancer 12:333, 1973. 2. Hoover R, and Fraumeni JF, Jr: Risk of cancer in renaltransplant recipients, Lancet 2:55, 1973. 3. Meadows AT, D'Angio GJ, Evans'AE, Harris CC, Miller RW, and Mike V: Oncogenesis and other late effects of cancer treatment in children, Radiology 114:175, 1975. 4. Li FP, Cassady JR, and Jaffe N: Risk of second tumors in survivors of childhood cancer, Cancer 35:1230, 1975. 5. Belpomme D; Carde P, Oldham RK, Math6 G, Jacquillat C, Chelloul N, Weil M, Auclerc G, Weisgerber C, Tanzer T, and Bernard J: Malignancies possibly secondary to anticancer therapy, Recent Results Cancer Res 49:115, 1975. 6. BeckwithJB: Mesenchymal renal neoplasms of infancy revisited, J PEDIATR Surg 9:803, 1974. 7. Garcia-Bunuel R, and Brandes D: Fetal hamartoma of the kidney: Case report, with ultrastructural cytochemical observations, Johns Hopkins Med J 127:213, 1970. 8. Favara BE, Johnson W, and Ito J: Renal tumors in the neonatal period, Cancer 22:845, 1968. 9. Wigger HJ: Fetal mesenchymal hamartoma of kidney. A tumor of secondary mesenchyme, Cancer 36:1002, 1975. 10. Fu Y, and Kay S: Congenital mesoblastic nephroma and its recurrence, an ultrastructural observation, Arch Pathol 96:66, 1973.